Crossject reports audited financial results for 2023
GlobeNewswire
*Dijon, France April 25, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company developing..
*Dijon, France April 25, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company developing..
*Ad hoc announcement pursuant to Art. 53 LR*
*Allschwil, Switzerland, April 04, 2024*
Basilea Pharmaceutica..
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company..